$CLDX Celldex Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Celldex Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Celldex Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Celldex Therapeutics, Inc. for free.
IRS Number: 133191702
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: CLDX
Company Address: 53 FRONTAGE ROAD SUITE 220 HAMPTON 08827
Phone number: 908-200-7500
Former name: T CELL SCIENCES INC, date of change: 1992-07-03
Former name: AVANT IMMUNOTHERAPEUTICS INC, date of change: 1998-08-28
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Celldex Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | CLDX | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 28.00 | 224,000 | 6,272,000 | 224,000 | |
| Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | M | 2.78 | 9,375 | 26,063 | 20,625 | |
| Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | M | 9.02 | 11,457 | 103,302 | 6,876 | |
| Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Sell | S | 18.61 | 9,375 | 174,436 | 208 | 9.6 K to 208 (-97.83 %) |
| Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Buy | M | 2.78 | 9,375 | 26,063 | 9,583 | 208 to 9.6 K (+4,507.21 %) |
| Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Sell | S | 18.61 | 11,457 | 213,175 | 208 | 11.7 K to 208 (-98.22 %) |
| Dec 16 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Buy | M | 9.02 | 11,457 | 103,302 | 11,665 | 208 to 11.7 K (+5,508.17 %) |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Martin Samuel Bates | SVP and CFO | Option Exercise | A | 10.38 | 105,600 | 1,096,128 | 105,600 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Heath-Chiozzi Margo | SVP of Regulatory A ... | Option Exercise | A | 10.38 | 84,000 | 871,920 | 84,000 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Cavanaugh Sarah | SVP of Corp Affairs ... | Option Exercise | A | 10.38 | 84,000 | 871,920 | 84,000 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Crowley Elizabeth | Sr. VP &CPDO | Option Exercise | A | 10.38 | 84,000 | 871,920 | 84,000 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 10.38 | 14,400 | 149,472 | 14,400 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Wright Richard M. | Sr. VP & CCO | Option Exercise | A | 10.38 | 42,000 | 435,960 | 42,000 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Young Diane C. | SVP, Chief Medical ... | Option Exercise | A | 10.38 | 72,000 | 747,360 | 72,000 | |
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 10.38 | 108,000 | 1,121,040 | 108,000 |